Page 7 - Pharmaceuticals
Stada receives takeover bids from Cinven & Advent International
The German drugmaker has reportedly received a € 3.5 billion bid from private equity group Cinven
 "Stada receives takeover bids from Cinven & Advent International")
Dr Reddy's expands European operations with launch of generics in France
First products, to be available in the hospital market, will belong to oncology & anti-infectives
 "Dr Reddy's expands European operations with launch of generics in France")
Aurobindo Pharma buys 4 biosimilars from Swiss firm TL Biopharmaceutical
Regulatory filing for these products, of which 3 are monoclonal antibodies, is expected in 2020-22
 "Aurobindo Pharma buys 4 biosimilars from Swiss firm TL Biopharmaceutical")
Alkem forms alliance with Haw Par to market Tiger Balm products in India
Through this, two companies aims to tap OTC analgesic market in India, estimated at Rs 2,000 crore
 "Alkem forms alliance with Haw Par to market Tiger Balm products in India")
Piramal Group buys UK-based Mallinckrodt's pharma products for $171 mn
The acquired portfolio of drugs belongs to spasticity and pain management categories
 "Piramal Group buys UK-based Mallinckrodt's pharma products for $171 mn")
Johnson & Johnson buys Swiss biopharma firm Actelion for $ 30 billion
It will also have 16% stake in Actelion's yet-to-be created R&D company
 "Johnson & Johnson buys Swiss biopharma firm Actelion for $ 30 billion")
Biocon bags Rs 460 crore contract for insulin in Malaysia
It will supply rh-insulin manufactured at its Malaysian plant to public sector hospitals & clinics
 "Biocon bags Rs 460 crore contract for insulin in Malaysia")
Lupin receives US FDA nod for anti-depressant drug paroxetin
The approved product is the generic version of Apotex Technologies' Paxil CR tablet
 "Lupin receives US FDA nod for anti-depressant drug paroxetin")
Zydus Cadila enters $8-bn US specialty pain market by buying Sentynl
With this, Zydus gains access to the specialty distribution network and large prescriber base in US
 "Zydus Cadila enters $8-bn US specialty pain market by buying Sentynl")
Zydus settles patent litigation for cholesterol lowering drug with Kowa
As per the deal, Zydus granted a license to market Livalo (pitavastatin calcium) tablet generics
 "Zydus settles patent litigation for cholesterol lowering drug with Kowa")
DoP exempts pharmaceutical companies from lowering drug prices based on WPI
NPPA had insisted that all cos revise prices based on WPI even if prices are lower than ceiling price
 "DoP exempts pharmaceutical companies from lowering drug prices based on WPI")
Valeant sells three skincare brands to L'Oreal for $1.3 billion
The company has also sold off Dendreon Pharma to China's Sanpower Group for $ 819.9 mn
 "Valeant sells three skincare brands to L'Oreal for $1.3 billion")
Aurobindo Pharma receives US FDA nod for epilepsy drug levetiracetam
The approved product has an estimated annual market size of $ 32 million in the US
 "Aurobindo Pharma receives US FDA nod for epilepsy drug levetiracetam")
Jubilant signs long-term supply contracts for radiopharmaceuticals in US
The US accounts for approximately 70% of the radiopharmaceuticals business' sales
 "Jubilant signs long-term supply contracts for radiopharmaceuticals in US")
Lupin receives US FDA nod for generic Evoxac capsule
Evoxac capsule, marketed by Daiichi Sankyo, had recorded sales of $ 40.8 million in the US
 "Lupin receives US FDA nod for generic Evoxac capsule")
Asahi Glass acquires CMC Biologics
CMC Biologics is one of the leading contract development & manufacturing organisations
 "Asahi Glass acquires CMC Biologics")
AdvaMed disappointed with DoP's decision to include stents in DPCO
The US-based medical tech association AdvaMed feels that the move hinders the fundamental right of a patient to have access to high-quality medical devices
 "AdvaMed disappointed with DoP's decision to include stents in DPCO")
Sun Pharma acquires Novartis' oncology brand Odomzo for $175 mn
Acquisition of Odomzo (sonidegib), which has marketing approval in over 30 countries including US, Europe and Australia, gives Sun Pharma its first branded oncology product
 "Sun Pharma acquires Novartis' oncology brand Odomzo for $175 mn")
Coronary stents now in DPCO 2013 list; NPPA to fix price in 60 days
The domestic and multi-national stent manufacturers have been at loggerheads on fixing prices
 "Coronary stents now in DPCO 2013 list; NPPA to fix price in 60 days")
Lupin launches anti-fungal drug voriconazole in US
Voriconazole tablet and oral suspension are generic versions of Vfend tablet and Vfend oral suspension - manufactured by PF Prism CV
 "Lupin launches anti-fungal drug voriconazole in US")
